Chronic disease surveillance is best described as

• A. A one-time survey to estimate disease frequency.
• B. A clinical trial to test a new treatment.
• C. A system that tracks infectious disease outbreaks only.
• D. Ongoing monitoring of chronic diseases using registries, such as diabetes incidence.

Answer: (D)

Chronic disease surveillance is ongoing monitoring of disease burden in the population over time, using systems like registries to collect regular data on people with specific conditions (for example, diabetes) to track how many new cases occur and how the condition evolves. This long-term, systematic approach lets public health see trends, measure burden, identify disparities, and evaluate prevention and care efforts.

The best description emphasizes that this isn’t a single snapshot or a trial. A one-time survey only provides a single moment in time, not sustained trends. A clinical trial tests a treatment, not surveillance. Tracking outbreaks of infectious disease focuses on infectious threats, whereas chronic disease surveillance covers non-communicable conditions and their long-term patterns. By contrast, ongoing monitoring using registries captures incidence and other meaningful metrics over time, making it the most accurate description.